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Summary
The evolutionary pressures that shaped the specificity and catalytic efficiency of enzymes can only
be speculated. While directed evolution experiments show that new functions can be acquired under
positive selection with few mutations, the role of negative selection in eliminating undesired activities
and achieving high specificity remains unclear. Here we examine intermediates along the ‘lineage’
from a naturally-occurring C12–C20 fatty acid hydroxylase (P450BM3) to a laboratory-evolved P450
propane monooxygenase (P450PMO) having 20 heme domain substitutions compared to P450BM3.
Biochemical, crystallographic and computational analyses show that a minimal perturbation of the
P450BM3 fold and substrate binding pocket accompanies a significant broadening of enzyme
substrate range and the emergence of propane activity. In contrast, refinement of the enzyme catalytic
efficiency for propane oxidation (~9,000-fold increase in kcat/Km) involves profound reshaping and
partitioning of the substrate access pathway. Remodeling of the substrate recognition mechanisms
ultimately results in remarkable narrowing of the substrate profile around propane and enables the
acquisition of a basal iodomethane dehalogenase activity as yet unknown in natural alkane
monooxygenases. A highly destabilizing L188P substitution in a region of the enzyme that undergoes
a large conformational change during catalysis plays an important role in adaptation to the gaseous
alkane. This work demonstrates that positive selection alone is sufficient to completely re-specialize
the cytochrome P450 for function on a non-native substrate.
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Introduction
Organisms can adapt to changing environments by acquiring alternative biosynthetic pathways
or detoxification mechanisms upon discovery and subsequent optimization of new enzyme
catalysts. Despite fundamental contributions from genetic and structural analyses,1,2 our
understanding of the forces driving the diversification and specialization of enzymes to occupy
new functional niches remains limited.
Directed evolution experiments have demonstrated that a small number of mutations can alter
enzyme specificity and enhance activity towards poor substrates.3–8 Catalytic promiscuity and
the ease with which these side activities can be improved provide a mechanism for enzyme
diversification in nature.9,10 Although there are cases in which having a broad substrate range
is linked to the physiological role of the enzyme (e.g. the ability of certain P450s to metabolize
a wide array of xenobiotics)11–14, many enzymes show exceptional power to discriminate
among similar substrates. How this specialization occurs is largely unknown. In the laboratory,
newly-specialized enzyme variants have been obtained by applying positive and negative
selection pressures which reinforce the desired phenotype while removing unfavorable side
activities.15,16 Negative selection may guide natural enzyme evolution in those cases where
a promiscuous activity has a negative impact on viability, leading, for example, to accumulation
of toxic intermediates or the waste of cellular resources. However, negative selection may not
be required to achieve high specificity. It has been postulated that ‘generalist’ enzymes may
have to trade off high activity on any one substrate for the ability to recognize and react with
a wide range of substrates.17 ‘Specialist’ enzymes could thus be the natural result of
maximizing activity on one particular substrate and not require negative selection to remove
other activities. Specialization under positive selection alone, however, has not yet been
demonstrated experimentally.
A large family of heme-containing monooxygenases comprising more than 7,000 known
members (http://drnelson.utmem.edu/P450.statsfile.html), the cytochrome P450s provide an
extraordinary example of how a conserved structural fold diversified over millions of years to
catalyze oxygenation reactions on widely different substrates.18–20 In addition to their key
roles in the breakdown of xenobiotics, cytochrome P450s catalyze important steps in the
biosynthesis of flavonoids21, alkaloids22, terpenes23, sterols24 and other natural products.
Unlike the xenobiotic-oxidizing P450s, these latter, anabolic enzymes tend to display narrow
substrate preference.25,26 We have recently reported the engineering of a proficient P450
propane monooxygenase (P450PMOR2) that catalyzes the subterminal hydroxylation of
propane with in vivo activities comparable to those of naturally-occurring alkane
monooxygenases from alkanotrophic organisms.27 This enzyme was obtained through
multiple rounds of laboratory evolution starting from P450BM3, a long-chain (C12–C20) fatty
acid hydroxylase from B. megaterium that has no measurable activity on propane.28 Propane
activity was first identified in a P450BM3 variant (139-3) that was selected for improved activity
towards octane.29 Further evolution of this variant was directed to improving activity on
propane.27,30,31
The entire ‘fossil record’—sequences and biochemical properties of all mutants in the lineage,
selection pressure and even the mutational process—is knowable for laboratory evolution
experiments.32 Here, we examine intermediates along the pathway to the P450 propane
monooxygenase to investigate how the applied evolutionary pressure affected the enzyme’s
structure and biochemical properties and to elucidate the mechanisms by which this novel,
non-native activity emerged and was refined.
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Results
The ‘evolutionary lineage’ connecting P450BM3 to P450PMO was reconstructed through eight
variants. The series begins with the octane-hydroxylating variant 139-3 and includes
subsequent variants that show at least a 2-fold increase in propane total turnover (TTN) and/
or >10% improvement in coupling efficiency for propane oxidation compared to their
predecessors.27,30,31 P450PMOR2 incorporates a reductase domain mutation (D698G)
beneficial to propane oxidation.27 To facilitate comparison with wildtype P450BM3 and other
variants, we generated P450PMO, where Gly698 was reverted to Asp by site-directed
mutagenesis. P450PMO is highly active, supporting 33,400 turnovers on propane (vs. 45,800
for P450PMOR2) with a coupling efficiency of 93% (vs. 98% for P450PMOR2). The
mutagenesis/screening methods used for the isolation of the selected variants together with
their amino acid substitutions are summarized in Table 1.
Biochemical analysis of P450PMO and its evolutionary precursors
Changes in the catalytic parameters and stabilities of the variants are reported in Figure 1.
Kinetic constants (Km, kcat) for propane oxidation were determined from Michaelis-Menten
plots of initial propanol formation rates at different propane concentrations. Since saturation
of 139-3 and J could not be achieved within the limits of propane solubility in water (≈1.6
mM), the kinetic parameters determined for these variants are approximate. Compared to 139-3
(wild-type P450BM3 has no detectable propane activity), total turnovers supported by
P450PMO increased 170-fold (Fig. 1(a)). This increase was accompanied by a 180-fold decrease
in Km, (from ~30 mM in 139-3 to 170 µM in P450PMO; Fig. 1(b)) and by a 45-fold increase
in kcat (from ~10 min−1 in 139-3 to 450 min−1 in P450PMO; Fig. 1(c)). Overall, P450PMO shows
a catalytic efficiency (kcat/Km) on propane of 4.4 × 104 M−1 s−1, which is approximately four
orders of magnitude greater than that of the first propane oxidizer, 139-3 (~5 M−1 s−1). Despite
the much reduced size and apolar nature of propane, P450PMO’s Km for propane oxidation is
comparable to that of P450BM3 for laurate oxidation (130 µM)33, while its catalytic efficiency
is only four times lower (cf. 1.9 × 105 M−1 s−1)33.
The coupling efficiency for propane oxidation improved from only 5–8% in the earliest
generations to 93% in P450PMO (Fig. 1(d)). The largest change in coupling efficiency (15%
→ 44%) was caused by the single L188P mutation between ETS8 and 19A12. Coupling of
product formation to NADPH oxidation approaches 100% only with ideal substrates for which
no competitive side reactions occur during the catalytic cycle.34 Thus, the increasing coupling
efficiency along the variant series suggests that the active site is becoming more optimized for
propane binding. This conclusion is supported by the kinetic data and is consistent with the
large decrease in Km.
How the evolution of propane activity affects the native activity was evaluated by measuring
variants’ activity on the long-chain fatty acids palmitate (C16) and laurate (C12) and comparing
those to that of wildtype P450BM3 (Fig. 1(e)). P450PMO has no detectable activity on laurate
and only marginal activity on palmitate (<150 TTN, or less than 0.5% that of P450BM3).
Palmitate is a significantly better substrate for P450BM3 than laurate in terms of catalytic
efficiency (6.0 × 107 M−1 s−1 vs. 1.9 × 105 M−1 s−1),35 which probably explains why laurate
activity was lost completely during P450PMO evolution. As Fig. 1(e) shows, native function
was only mildly affected in the first two intermediates, 139-3 and J (J displays 31% (palmitate)
and 61% (laurate) activity relative to wildtype). A more significant decrease was observed with
35E11 (<10% rel. act.). The mutations accumulated in 35E11 include R47C (Table 1), which
removed a side chain important for recognition of the carboxylate moiety in fatty acid
substrates.36 We reverted Cys47 to Arg in both 35E11 and P450PMO to examine its
contribution to the loss of fatty acid activity. In 35E11, C47R led to moderate recovery of
activity (laurate: 8→24% rel. act.; palmitate: 5→18% rel. act.), whereas P450PMO-C47R still
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had no measurable activity on laurate and negligible activity on palmitate (~180 TTN). These
results indicate that refinement of propane activity came at the cost of the original function,
regardless of the presence of specific fatty acid-binding determinants. In our experiments, no
detectable activity on propane or fatty acids corresponds to a catalytic efficiency of less than
1 M−1 s−1. Therefore, from P450BM3 to P450PMO the overall change in specificity is at least
a factor of (4.4 × 104/1) / (1/1.9 × 105) ~ 1010.
To establish the impact of the accumulated mutations on enzyme stability, T50 values were
determined from heat-inactivation curves of the heme-dependent CO-binding spectral shift
(Fig. 1(f)). These analyses show a gradual but continual decrease in the heme domain stability
along the evolutionary pathway, reflecting the fact that stability was not under selection. The
average impact of each mutational event on stability varies considerably though, as shown by
the plot of per-mutation stability penalties (Fig. 1(g)). With 35E11, the much-reduced stability
compared to wildtype (ΔT50 = −11.6 °C) prevented further evolution and necessitated the
stabilization step that led to ETS8, at which point a new beneficial mutation (L188P) could be
found.27 To investigate whether L188P exerts the same effect in the background of the less-
stable precursor, we introduced L188 in 35E11, where it caused a perturbation in the heme
environment as indicated by the appearance of a 420-nm peak (~40%) in the CO-difference
spectrum of the purified enzyme (data not shown). Furthermore, in contrast to the ~300%
increase in TTNpropane as a result of Leu188 mutation to proline during ETS8 → 19A12
transition, L188P generated only a small improvement (<40%) in 35E11. Altogether, these
results highlight the role of the stabilizing mutations in enabling the fold to accommodate the
beneficial but destabilizing L188P substitution. Saturation mutagenesis of position 188 in
19A12 confirmed proline as the best possible amino acid substitution (data not shown).
Substrate specificity profiles
Specificities of the evolved P450 variants were investigated using the alkane series from C2
(ethane) to C10 (decane). Total turnovers—a cumulative measure of both catalytic and coupling
efficiency—were determined for each substrate-P450 pair under identical reaction conditions
(Supplementary Table S1). To enable comparison, TTNs were normalized to the highest value
in the series (MTN = Maximal Turnover Number). The resulting profiles (Fig. 2(a)) reveal a
remarkable shift in substrate preference along the evolutionary path. The activity of
P450BM3 on the C2–C10 alkanes was marginal (MTN = 160) and restricted to Cn > 8 alkanes.
In the earliest steps, substrate preference centered on the medium-chain alkanes (C8-C7),
extending only later (35E11) towards shorter alkanes. A change in substrate preference
appeared with 19A12. Subsequent variants 11-3, 1-3 and P450PMO showed a progressive
decrease in TTN with alkane length. In P450PMO, specificity along the alkane series has
become remarkably restricted around propane: TTN drops by 55% for butane and by 95% for
pentane.
Initial rates of product formation were compared for C3 to C9 alkanes (Fig. 2(b)). In the earliest
intermediates, the preference for longer-chain alkanes is indicated by high vo(C9)/vo(C3) ratios
(51 for 139-3; 14 for J). This ratio decreased to ~1 in 35E11 and then switched in favor of the
smaller alkane in subsequent generations. In P450PMO, the product formation rate was highest
on propane and decreased along the alkane series (vo(C9)/vo(C3) = 0.039). Overall, the ratio
of the rates on propane vs. nonane changed 1,300-fold from 139-3 to P450PMO.
Upon substrate binding and displacement of the water ligand from the heme iron in the low-
spin ferric heme converts to a high-spin configuration, which appears as a blue shift of the
Soret band from ~417 nm to ~392 nm.37 How the variants interact with alkanes was further
investigated by testing the heme iron spin shifts in the presence of propane, pentane and octane
(Fig. 2(c)). High-spin content was estimated based on reference spectra of P450BM3 in complex
with increasing amounts of palmitate. Octane binding induced between 35 and 50% spin shift
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in 139-3 and later generation variants. Significant propane- and pentane-induced spin shifts
(>25%) were observed only in the last three variants studied. Interestingly, 19A12 and its
successors showed partial high-spin content (5–10%) even in the absence of substrate,
suggesting that the mutations displace water in the active site or interfere with hydrogen
bonding to the axial water ligand.38
In a further probe of the active site, we also tested P450PMO and its precursors on three
structurally diverse terpenes: guaiol, valencene, and limonene. Oxidation products were
quantified by GC (Fig. 3). For all variants, the TTN changed inversely with substrate size
(guaiol < valencene ≪ limonene). Early intermediates 139-3 and particularly J showed the
highest activities with all three, demonstrating substrate promiscuity that extends beyond
alkanes. A large drop in activity was observed in the J → 35E11 transition, followed by a
gradual but steady decrease as activity on propane increased. P450PMO behaved similarly to
P450BM3, showing negligible activity on guaiol and valencene (TTN < 150) and very weak
activity on limonene (TTN: 580).
Halomethane dehalogenase activity
P450PMO supports thousands of turnovers on ethane (TTN ~ 2,450), despite the higher C-H
bond strength (101.0 for ethane vs. 98.6 kcal mol−1 for the sub-terminal C-H of propane). To
determine whether P450PMO can insert oxygen into C-H bonds stronger even than those of
ethane, P450PMO activity was tested on halomethanes (CH3Cl, CH3Br and CH3I), which have
molecular sizes and C-H bond energies intermediate between those of methane and
propane39 (Supplementary Figure S2). Reactions with halomethanes were analyzed for
formation of formaldehyde (Fig. 4(a)) due to the expected α-elimination of HX upon
hydroxylation. Measurable bromomethane activity first appeared in 35E11 and increased
through the series at a level that is 1–5% of the propane activity (Fig. 4(b)). Despite the ~1 kcal
mol−1 weaker C-H bond, chloromethane activity emerged only later (19A12) and was detected
at lower levels (0.5–1% of propane activity), reflecting the preference of these variants for
propane-sized substrates. Unlike CH3Cl and CH3Br, iodomethane is not oxidized by
mammalian P450s.40 Interestingly, P450PMO and its precursor 1–3 exhibited detectable
activity on iodomethane, albeit with low turnover rates (0.5–1 min−1). These results provide
the first demonstration that a 103.0 kcal mol−1-sp3 C-H bond is energetically accessible to
oxygen insertion by a P450 enzyme.
Structural investigation of the P450PMO lineage
Crystallization experiments were undertaken to investigate structural changes along the
lineage. While P450PMO and other variants failed to yield diffraction-quality crystals, early
intermediate 139-3 could be crystallized in the presence of N-palmitoylglycine (NPG). The
structure of the complex was solved at 2.6 Å resolution with R=0.21 and Rfree=0.26 (see Table
2 for data collection and refinement statistics). The asymmetric unit contains two chains, A
and B. The structure of P450BM3 in complex with NPG is available.41 Superposition of the
139-3 and P450BM3 complexes revealed no gross changes in the enzyme fold (Fig. 5(a), average
Cα RMSD = 0.5 Å). The largest deviations (>1 Å) were in the N-terminal region (Thr1-
Leu20), the loop in β-sheet β1 (Pro45-Arg47), the region between helix-H and -I (Pro243-
Glu247), and the 310-helix between Glu380 and Ser383 (Fig. 5(a) and Supplementary Figure S3).
The NPG ligand was found to adopt a more extended conformation in complex with 139-3,
and a slight movement of β-sheet β1 towards helix-F caused a restriction at the entrance of the
substrate access channel (Fig. 5(a)). The relative positions of the residues critical for fatty acid
interaction (Arg47, Tyr51) were unaltered. V78A and A184V are in the active site, and are at
short distance from one another (Fig. 5(b)). V78A is responsible for expansion of the
hydrophobic pocket near the heme, whose volume increased by 29 Å3 (Fig. 6(a)). In 139-3,
Val184 forms a much tighter (3.3 Å vs. 4.2 Å) contact with Leu437 across the substrate channel.
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Assuming octane orients similarly to NPG in the active site, Leu437 would establish closer Van
der Waals contacts near the terminal carbon of octane and enable more efficient exclusion of
the shorter substrate from the solvent. This also translates into a change of the substrate
orientation in the active site as reflected by the regioselectivity for octane oxidation in 139-3,
which hydroxylates primarily at the 2-position (55% 2-octanol, 20% 3-octanol, 18% 4-octanol
and 7% ketone) vs. the wildtype enzyme, which prefers the 3- and 4-positions (5% 2-octanol,
49% 3-octanol, 43% 4-octanol and 3% ketone).
Conservative structural models of 35E11, 19A12, 1–3 and P450PMO were calculated based on
the 139-3 crystallographic model (chain B) using the Rosetta42 structure prediction algorithm.
In 35E11, three mutations (V78F, A82S, A328F) cause a major change in the substrate channel.
Specifically, Phe328 (in concert with Leu437 and Ala74) constricts the channel so that the
contiguous substrate access pathway found in P450BM3 and 139-3 (Fig. 6(b)) appears
compartmentalized into an inner heme pocket (HP) and a more solvent-accessible substrate
channel (SC) (as mapped using a probe radius of 1.4 Å). The total volume of these cavities is
dramatically reduced compared to 139-3 (ΔVSC+HP = −127 Å3; Fig. 6(a)). Experimental data
support these calculations. The >70% drop in activity towards the terpenes suggests a much
reduced accessibility of 35E11’s active site compared to the preceding variants (139-3, J),
while the increased regioselectivity with C7–C9 alkanes (>90% 2-alcohol) is indicative of a
significant decrease in these substrates’ conformational freedom within the active site.
In contrast to the other mutations, L188P was associated with a very unfavorable energy. The
structure of 19A12 was therefore calculated allowing backbone motion for residues 185 to 191
and updating the conformation of this region using Loopy42. In the resulting model, Pro188
causes partial unwinding of helix-F C-terminus and removes Leu188 steric bulk, reducing the
distance between helix-F and adjacent helix-B' (Fig. 5(c)). These changes appear to have
significant impact on the properties of the enzyme (see Discussion). In P450PMO, the active
site mutations A184V, S74E, S82G further restrict the substrate channel (Fig. 6(a)). This
enables a more productive interaction of the enzyme with the substrate as indicated by the
higher high-spin content upon propane binding and increased coupling in propane oxidation.
The G443A mutation was found to affect the propane oxidation rate (2-fold) but has little effect
on coupling (91%) and Km for propane (170 µM).
Discussion
Propane is one-fifth the size of a typical cytochrome P450BM3 substrate and lacks the
carboxylate moiety and long aliphatic chain through which the fatty acid interacts with the
enzyme (Fig. 2a).19,36 By studying the intermediates along the pathway to P450PMO, we were
able to observe how the enzyme has re-elaborated its substrate recognition strategies to achieve
catalytic proficiency on this gaseous alkane. The 139-3 crystal structure shows that broadening
of the substrate range of P450BM3 to include octane and other medium-chain alkanes occurred
with minimal perturbation of the overall fold. An enlarged hydrophobic pocket near the heme
(Fig. 6(a–b)) appears to provide an energetically more favorable environment for binding to
octane while also enabling the emergence of propane activity. These changes interfered only
slightly with the native enzyme activity, which decreased by a factor of ~2. The latter reflects
a previously-observed feature of enzyme evolution: improvement of side, or ‘promiscuous’,
activities under positive selection pressure often comes with only marginal cost to the native
activity.17 The substrate range of variants 139-3 and J appears to be broad and include other
hydrophobic substrates, i.e. terpenes, that differ considerably from those used for activity
screening (octane and propane, respectively). This ‘generalist’ character has been observed in
other early products of directed evolution such as, for example, in engineered variants of a
beta-glucuronidase.4
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In the next few generations, the prevailing strategy for improvement of propane activity
involved compartmentalization and restriction of the active site cavity (cf. 35E11). This
facilitated the interaction of the enzyme with the smaller substrate, as evidenced by a) a 7-fold
increase in TTNpropane, b) appearance of the heme spin shift (8%) upon propane binding, and
c) a decrease in Km to the sub-millimolar range. The substrate preference remained centered
on C6–C8 alkanes, but a significant decrease (>90%) in the native function was observed. The
‘turning point’ in substrate specificity in the next step (35E11 → 19A12) was induced by a
single amino acid substitution, L188P (ETS8’s profile overlaps with that of 35E11, data not
shown). In the 139-3 structure, Leu188 lies at the C-terminus of helix-F which, together with
helix-G, forms a lid that undergoes conformational change upon substrate binding (Fig. 5(a)).
36 L188P removes the intra-strand H-bonds established by the Leu188 amide NH and is
associated with a perturbation of the surrounding helical region (Fig. 5(c)) and a large
destabilizing effect (ΔT50 = −3.3°C vs. mean value of −0.6°C/mutation, Fig. 1(g)). The stability
cost of this mutation is offset by the advantage—the largest on a per-residue basis—it provides
in propane oxidation, reflected in a 3-fold improvement in TTN and coupling efficiency, a 2-
fold increase in turnover rate constant kcat, and a 2-fold reduction in Km (830 µM in ETS8
vs. 475 µM in 19A12). By bringing helix-F and helix-B' in closer proximity, this mutation may
force the enzyme to adopt a conformation similar to the closed, catalytically more favorable
one.36
After 19A12, a gradual decrease in activity towards longer alkanes accompanied the increased
activity on propane, even though no negative selection was applied during the evolution of
these variants to specifically favor this trend. Mapping of the substrate access pathway revealed
a twisted path connecting the exterior to the heme (Fig. 6(b)). This configuration apparently
provides an effective solution to channeling propane to the active site. It is also likely to hamper
diffusion of longer-chain alkanes to and from the active site, explaining the observed difference
in oxidation rates and total turnover numbers observed within the alkane series. A comparison
can be made with the soluble non-heme diiron methane monooxygenase (sMMO), an
evolutionarily unrelated enzyme found in methanotrophic bacteria.43 Studies addressed the
question of how sMMO can discriminate methane from hundreds of other potential substrates
with weaker C–H bonds.44,45 The α subunit of sMMO hydroxylase domain was found to
direct methane to the active site pocket through a sequence of five buried cavities.45 The
remarkable restriction (ΔV = −248 Å3, Fig. 6(a)) and compartmentalization of the substrate
access pathway along the P450PMO lineage suggest a similar adaptive strategy to dealing with
the problem of recognizing a small gaseous substrate. This can be rationalized in light of the
negligible binding energy contribution (−ΔΔG < 3–4 kcal/mol) provided by neutral ligands
with fewer than five non-hydrogen atoms46 and the fact that propane presumably has
insufficient binding energy to induce the lid closure and accompanying conformational changes
that characterize the interaction of P450BM3 with long-chain fatty acids36,47. In contrast to
the highly hydrophobic ‘chambers’ in sMMO, however, the substrate access channel in
P450PMO has a more pronounced polar character. In particular, a progressive partitioning
between a hydrophobic heme pocket and a relatively more polar substrate channel was
observed along the variant series (Fig. 6(a)), a trend which culminated with a charged residue
(Glu74) interposing between the two (Fig. 6(b)). Noteworthy in this regard was the progressive
increase in polarity and bulkiness of residue 74 over the final evolutionary steps: Ala (19A12)
→ Ser (1–3) → Glu (P450PMO).
While optimal for oxidation of the gaseous substrate, the acquired changes are incompatible
with the native and other activities. In P450PMO there remains little trace of the original
P450BM3 function. Furthermore, in contrast to the earliest intermediates, which exhibit broad
substrate ranges, P450PMO appears to have completely re-specialized, displaying very narrow
substrate tolerance within the C2–C10 alkane series and little activity towards other, unrelated
substrates (Fig. 2, 3). Thus, the re-specialization of P450PMO is induced by the same forces
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that pushed for optimization of the function under selective pressure and appears to be a
consequence of acquisition of catalytic proficiency with propane.
Altogether, our results have several important implications. First, these data show that, far from
being ‘evolutionary dead-ends’, specialized enzymes can serve as starting points for divergent
trajectories that lead to other, specialized members of the same enzyme family. Also, we
provide the first experimental evidence that positive selection alone is sufficient to induce
complete re-specialization of a P450 enzyme, which suggests that negative selection need not
have played an important role in the evolution of specialized members of this and possibly
other enzyme families. Finally, the emergence of iodomethane dehalogenase activity in
P450PMO is noteworthy, as mammalian P450s and soluble MMO do not exhibit it.40,48
Iodomethane is known to be degraded by a very small subset of methylotrophic species, using
enzymes such as corrinoid-dependent methyltransferases.49 The propane-adapted features of
P450PMO’s active site enable the emergence of a basal activity towards this substrate, thus
providing an alternative enzymatic strategy for the degradation of this compound and further
expanding the range of known P450 activities.
Materials and Methods
Kinetic, biochemical, and biophysical analyses
Enzymes were expressed and purified as previously described.27 P450PMO, P450PMO(C47R),
35E11(C47R), and 35E11(L188P) were obtained by site-directed mutagenesis (see
Supplementary Table S2 for primer sequences). Michaelis-Menten plots for propane oxidation
(e.g. Supplementary Fig. S1) were obtained varying propane concentration by dilution of
propane-saturated solutions (≈1.6 mM). Reactions (5 mL) were carried out at 25°C in 100 mM
KPi buffer pH 8.0 using 100–400 nM enzyme and 1 mM NADPH. After 20 seconds, reactions
were stopped with 200 µL H2SO4 conc. and analyzed by GC-ECD as previously described.
27 Initial rates (20 sec) for alkane oxidation were measured using 1 mM substrate (2% ethanol),
50 nM P450, 1 mM NADPH. Reactions were stopped with 100 µL HCl 2 N, extracted with
CH2Cl2 and analyzed by GC-FID. Coupling efficiency corresponds to the ratio between
propanol formation rate and NADPH oxidation rate in the presence of propane and was
measured as previously described.27 Half-denaturation temperatures (T50) were determined
as follows. Samples of purified enzyme (~ 3 µM) were incubated for 10 minutes at different
temperatures (from 20°C to 60°C) in a PCR thermocycler. After centrifugation, 160 µL protein
solution were mixed with 40 µL 0.1 M sodium hydrosulfite on a microtiter plate and incubated
for 10 minutes with carbon monoxide in a sealed chamber. T50 values were calculated from
heat-inactivation curves of CO-binding difference spectra. Alkane-induced spin shift were
recorded on Shimadzu UV-VIS using P450 (2 µM) and 1 mM octane, pentane, or propane (2%
ethanol). High-spin content was estimated by comparison with spectra of P450BM3 and
palmitate mixtures. Reactions with alkanes from pentane to decane were carried out at 3 mL-
scale using KPi buffer containing 2% ethanol, 50 nM enzyme, 1.6 mM alkane, and a cofactor
regeneration system (CRS: 10 U/mL isocitrate dehydrogenase, 7 mg/mL isocitrate, 0.15 mg/
mL NADP+). Reactions were sealed, stirred for 24 hours (4°C), extracted with CH2Cl2 and
analyzed by GC-FID. Reactions with ethane, propane, and butane were carried out as described
for C5–C10 alkanes using alkane-saturated buffers. All kinetic and biochemical measurements
were performed in triplicate. For C5–C10 alkane reactions, GC analyses were carried out using
a Shimadzu GC-17A gas chromatograph, Agilent HP5 column (30 m × 0.32 mm × 0.1 µm
film), 1 µL injection, FID detector, and the program: 250 °C inlet, 50 °C for 3 min, 5°C/min
to 100°C, 25°C/min to 230 °C, and 230 °C (3 min). For butane and propane reactions (TTN),
GC analyses were carried out using a Hewlett-Packard 5890 Series II Plus gas chromatograph,
Supelco SPB-1 column (60 m × 0.52 mm × 0.5 µm film), 0.5 µL injection, FID detector, and
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the program: 250 °C inlet, 80 °C for 2 min, 10°C/min to 110°C, 25°C/min to 275 °C, and 275
°C (2.5 min).
Analysis of fatty acid and terpene activity
Reactions with laurate and palmitate were carried out at 2 mL-scale using 2 mM fatty acid,
100–500 nM enzyme, and CRS. After stirring for 24 hours, solutions were acidified with HCl,
extracted with hexane, dried over Na2SO4, added with 1:10 v/v N-methyl-N-
trimethylsilylheptafluorobutyramide and analyzed by GC-FID using Shimadzu GC-17A GC,
Agilent HP5 column, 1 µL injection, and the program: 300 °C inlet, 100 °C for 2 min, 15°C/
min to 150°C, 10°C/min to 250 °C, and 250 °C (4 min). Reactions with terpene substrates were
carried out at 2 mL-scale using 1 mM guaiol, 1 mM valencene, or 5 mM limonene, 0.5 µM
enzyme, and CRS. After stirring for 24 hours, reactions were extracted with 200 µL CHCl3
and analyzed by GC-FID using Shimadzu GC-17A GC, Agilent HP5 column, 1 µL injection,
FID detector, and the program: 300 °C inlet, 70 °C, 10°C/min to 210°C, 50°C/min to 260 °C,
and 260 °C (2 min). All activity measurements were performed in triplicate.
Reactions with halomethanes
Reactions were carried out at 1 mL-scale using halomethane-saturated 100 mM KPi pH 8.0,
50 to 500 nM enzyme, and CRS. Buffers were prepared using HPLC-grade water and
autoclaved twice prior to use. After 30 min reaction, 1 mL-aliquots were mixed with 50 µL
o-(2,3,4,5,6-pentafluorobenzyl)-hydroxylamine hydrochloride (Sigma) in formaldehyde-free
water (17 mg/mL) and incubated 15 min at 25°C. Mixtures were mixed with 10 µL 25 mM 1-
bromohexane (internal standard) and extracted with 500 µL hexane. Organic phase were
diluted 1/100 v/v and analyzed by GC-ECD using Shimadzu GC-17A gas chromatograph,
Agilent HP1 column (30 m × 0.53 mm × 2.65 µm film), 1 µL injection and the program: 70°
C inlet, 45°C 1 min, 15°C/min to 200°C, 50°C/min to 220°C, and 220°C (3 min). A calibration
curve was constructed from freshly prepared solutions of formaldehyde. All measurements
were performed in triplicate.
Protein crystallization
For crystallization, the heme domain of 139-3 (1–455 residues; 139-3H) was cloned into EcoRI/
KpnI cassette of vector pProEX-1 using 5’-
GATCCGGAATTCATGACAATTAAAGAAATG-3’ and 5’-
GCTAAAAAAGTATAGGTACCAAGCCTTGCC-3’ as forward and reverse primers,
respectively. Recombinant E. coli DH5α cells were grown in TB medium and induced with
0.6 mM IPTG at OD600=0.7. Flasks were transferred to 25°C and harvested after 20 hours.
Cells were lysed in 50 mM sodium phosphate (pH 7.4), 100 mM NaCl, 1 mM
phenylmethanesulfonyl fluoride (PMSF) and 10 mM β-mercaptoethanol (buffer A). Cell lysate
was loaded onto a Ni-NTA agarose column pre-equilibrated with buffer A. After washing the
column with 50 mM NaHPO4 (pH 7.4), 100 mM NaCl, 10 mM β-mercaptoethanol and 10%
glycerol (buffer B), bound protein was eluted with buffer B in the presence of 100 mM
imidazole. After concentration, the protein was loaded onto a Sephacryl S200 gel filtration
column re-equilibrated with buffer A. Purified 139-3H was mixed with NPG and crystallized
by hanging drop vapor diffusion method from a protein solution at 40 mg/mL and a solution
containing 100 mM MOPS (pH 7.0), 50 mM LiBr, 20% PEG 20,000. Crystals were soaked in
2 M sodium malonate as cryoprotectant prior to data collection.
Data Collection and Structure Determination
X-ray diffraction data were collected on beam line 5.0.1 at ALS (Berkeley, CA) using an ADSC
Quantum 4, CCD detector. Optimization of data collection was guided by the STRATEGY
function of MOSFLM.50 All data were reduced using DENZO and scaling and rejections were
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performed with SCALEPACK.51 The structure was solved using molecular replacement as
implemented in AMORE in CCP4 suite52 and the structure of P450BM3 complexed with
palmitoleic acid (PDB ID code 1FAG)36 as search model. Two solutions in the asymmetric
unit were found with using data between 43.0–3.0Å. Phases were improved and extended to
2.65Å over 50 iteration of density modification using DM53 as well as two-fold non-
crystallographic symmetry averaging. The structure was further refined using the graphical
model building program O54 and CNS55 to a final resolution of 2.65 Å. Backbone geometry
was checked in PROCHECK56. Data collection and refinement statistics are provided in Table
2. Structural coordinates are deposited in the Protein Data Bank under ID code 3CBD.
Model Calculations and Substrate Access Pathway Analysis
Structural models were calculated with Rosetta42 using the structure of intermediate 139-3
(chain B) as reference model. The positions of mutated side chains were optimized (including
off-rotamer continuous optimization) using full atom Rosetta energy function. To
accommodate L188P, the backbone between residues 185 and 191 was updated using Loopy.
42 Substrate access pathways were analyzed with Quickhull57 using Cys400 and Cα atoms of
residues 72–75, 78, 82, 87, 88, 177, 182, 185, 259, 263–268, 328–332, 357, 435–439 as
reference points and constructing a convex hull around these points. Within the hull, a “cast”
was formed by placing dummy atoms at all 0.5 Å grid points at least 3 Å from a protein atom.
Substrate pathways were visualized displaying the surface of the cast with PyMOL. Solvent
excluded volumes were computed using MSMS58 with a probe radius of 1.4 Å and a density
of 3.0/Å2. Reported volume and surface area values refer to volume occluded and the area
buried, respectively. Based on MSMS per atom surface area breakdown, polar and nonpolar
surface areas were measured using OPLSaa charges and grouped atoms with |q| < 0.2 into the
nonpolar category.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Abbreviations
PMO, propane monooxygenase; MMO, methane monooxygenase; TTN, total turnover
number.
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Fig. 1. Functional and kinetic properties of P450PMO evolutionary intermediates
(a) Total turnover numbers for propane hydroxylation (mol propanol/mol P450). (b) Km values
and (c) catalytic rate constants (kcat) for propane oxidation. (d) Coupling efficiency, as given
by propanol formation rate / NADPH oxidation rate. Errors are within 10%. (e) Relative activity
with palmitate and laurate, as compared to P450BM3. (f) Enzyme thermostability, reported as
T50 values from heat inactivation of heme domain after 10 min incubation. (g) Average stability
penalty per amino acid substitution for each step in the lineage.
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Fig. 2. Evolution of a P450 propane monooxygenase from a long-chain fatty acid hydroxylase
(a) Substrate specificity profiles of P450PMO and its evolutionary intermediates on the C2–
C10 alkane series. Maximal turnover numbers: P450BM3 = 160; 139-3 = 2,100; J = 3,450;
35E11 = 6,350; 19A12 = 10,500; 11-3 = 13,200; 1–3 = 19,200; P450PMO = 33,400. The dashed
line indicates the profile of the preceding variant. Numbers indicate the number of heme domain
mutations with respect to P450BM3 and the preceding variant (brackets). The chemical
structures next to the arrows refer to the selective pressure (octane or propane). The preferred
substrates of P450BM3 (palmitate) and P450PMO (propane) are displayed as space-filling
models. (b) Initial oxidation rates with different alkanes, as measured by total nmol of
hydroxylated alkane per nmol enzyme per minute. (c) Alkane-induced shifts of heme spin state
with different substrates, as determined from 350–500 nm spectra.
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Fig. 3.
Activities of P450PMO evolutionary intermediates on terpene substrates, as determined by GC
analysis of the oxidation products.
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Fig. 4. Halomethane dehalogenase activities of P450PMO evolutionary intermediates
(a) GC traces of P450PMO reactions with CH3Cl, CH3Br and CH3I after formaldehyde
derivatization. (b) Halomethane dehalogenase activities, as measured by the rate of
formaldehyde formation.
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Fig. 5. Structure of variant 139-3
(a) Superposition of NPG-bound structures of P450BM3 (orange, PDB code 1JPZ41) and
evolutionary intermediate 139-3 (green, this work: PDB code 3CBD). The mutated residues,
fatty acid-binding Arg47 and Tyr51, and Leu188 are displayed as stick models. The heme is
displayed as a space-filling model. N- and C-termini and selected secondary structure elements
are indicated with capital letters. (b) Contacts of V78A and A184V substitutions with Leu347
and the bound ligand in 139-3 (green). (c) Superposition of 139-3 structure (green) and 19A12
model (red) illustrating the helix-capping role of Leu188 and the disruption of helical
conformation as a consequence of the L188P mutation in 19A12.
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Fig. 6. Substrate access pathway
(a) Volumetric restriction and compartmentalization of the substrate access pathway during
the transition of P450BM3 to P450PMO (left panel). The A328F mutation in 35E11 interrupts
the contiguity of the path by defining an inner cavity (at the heme pocket) from the remaining
of the access path (indicated as ‘substrate channel’). The computed fraction of polar surface
area (right panel) shows an increasing difference in polarity between the inner and outer
compartments along the lineage. (b) Surface representations of the substrate access pathway
in P450BM3 structure, 139-3 structure, and P450PMO structural model. The cavity above the
heme first expands to accommodate octane (in 139-3). Upon selection for propane activity,
this space becomes narrowly confined by a phenylalanine triad (black arrows) and segregated
from the outer substrate channel through the interaction of Leu347 with opposing Glu74.
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Table 1
Summary of directed evolution steps and amino acid substitutions accumulated in P450BM3 variants.
Variant Target
substrate
Mutagenesis
method
Heme domain substitutionsa
139-3b octane random / recombination V78A, H138Y, T175I, V178I, A184V,
H236Q, E252G, R255S, A290V, A295T,
L353V
Jc propane DNA shuffling Y138H, I178V, F205C, S226R, T295A
35E11d propane site-saturation / recombination R47C, A78F, A82S, K94I, P142S, A328F
ETS8e stability/propane site-directed L52I, I366V
19A12e propane random L188P
11-3e propane site-saturation A74S
1-3e propane recombination V184A
P450PMO propane saturation-recombination / site-directed A74E, S82G, A184V, G443A
a
Substitutions are given with respect to the preceding variant.
b
From ref. 29.
c
From ref. 31.
d
From ref. 30. This and subsequent variants carry also two mutations in the reductase domain (E464G, I710T). While important for ethane oxidation,
these mutations have only a small effect on propane oxidation.
e
From ref. 27.
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Table 2
Data collection and refinement statistics.
A. Data collection
Max. resolution (Å) 2.6
Unit cell dimensions
a (Å) 62.05
b (Å) 127.82
c (Å) 183.94
Space group P212121
Total observations 154,017
Unique reflections 42,077
Redundancy 3.66
Completeness1 97.9 (92.6)
Rsym
1,2 0.0078 (0.784)
<I>/σ1 8.5 (1.3
B. Refinement
R factor3 0.21
Rfree 
4 0.26
No. of protein atoms 7334
No. of hetero atoms 130
No. of water molecules 341
RMSD from ideal
bond length (Å) 0.007
bond angle (deg.) 1.4
PDB entry 3CBD
1
Values in parentheses are for highest-resolution shell.
2
Rsym = Σ|I - <I> | /Σ I, where I is the observed intensity and <I> the averaged intensity of multiple symmetry related observations of the reflection. Note:
Backbone geometry analysis revealed only one residue (Leu437) in a disallowed region of Ramachandran plot, which is nevertheless very well defined
with clear density.
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